Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Authors

RÁČIL Zdeněk TOŠKOVÁ Martina DVOŘÁKOVÁ Dana JEŽÍŠKOVÁ Ivana RÁZGA Filip BUREŠOVÁ Lucie TIMILSINA Shira MAYER Jiří

Year of publication 2012
Type Article in Periodical
Magazine / Source American Journal of Hematology
MU Faculty or unit

Central European Institute of Technology

Citation
Web http://onlinelibrary.wiley.com/doi/10.1002/ajh.22213/abstract
Doi http://dx.doi.org/10.1002/ajh.22213
Field Oncology and hematology
Keywords molecular relapse; AML; clofarabine monotherapy
Description Few studies have examined the treatment of molecular relapse in patients with acute myeloid leukemia (AML) using different treatment regimens. We describe for the first time in the literature experiences with administration of clofarabine monotherapy in the treatment of eight patients with AML with molecular relapse of the disease.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.